255 related articles for article (PubMed ID: 18723067)
1. The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10.
Lu XL; Jiang XB; Liu RE; Zhang SM
Vaccine; 2008 Oct; 26(42):5352-7. PubMed ID: 18723067
[TBL] [Abstract][Full Text] [Related]
2. Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma.
Jiang XB; Lu XL; Hu P; Liu RE
Vaccine; 2009 Oct; 27(44):6210-6. PubMed ID: 19699331
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy with flk1-based DNA vaccine and interleukin-12 results in enhanced antiangiogenic and antitumor effects.
Feng KK; Zhao HY; Qiu H; Liu JX; Chen J
Cancer Lett; 2005 Apr; 221(1):41-7. PubMed ID: 15797625
[TBL] [Abstract][Full Text] [Related]
4. A combination of flk1-based DNA vaccine and an immunomodulatory gene (IL-12) in the treatment of murine cancer.
Keke F; Hongyang Z; Hui Q; Jixiao L; Jian C
Cancer Biother Radiopharm; 2004 Oct; 19(5):649-57. PubMed ID: 15650458
[TBL] [Abstract][Full Text] [Related]
5. [Specific anti-glioma angiogenesis immune response induced by attenuated Salmonella typhimurium vaccine expressing vascular endothelial growth factor receptor-2].
Feng KK; Zhao HY; Qiu H; Chen J
Ai Zheng; 2005 May; 24(5):548-53. PubMed ID: 15890095
[TBL] [Abstract][Full Text] [Related]
6. [Construction of a DNA vaccine against extracellular domain 1-3 of Flk1 and its inhibitory effect on growth of liver cancer cell line H22].
Lu F; Qin ZY; Li YM; Qi YX; Liu YF; Yang WB
Ai Zheng; 2004 Dec; 23(12):1616-21. PubMed ID: 15601548
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.
Bequet-Romero M; Ayala M; Acevedo BE; RodrÃguez EG; Ocejo OL; Torrens I; Gavilondo JV
Angiogenesis; 2007; 10(1):23-34. PubMed ID: 17273909
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination.
Pan J; Heiser A; Marget M; Steinmann J; Kabelitz D
Gene Ther; 2005 May; 12(9):742-50. PubMed ID: 15729371
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.
Tseng JF; Farnebo FA; Kisker O; Becker CM; Kuo CJ; Folkman J; Mulligan RC
Surgery; 2002 Nov; 132(5):857-65. PubMed ID: 12464871
[TBL] [Abstract][Full Text] [Related]
10. Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1.
Wang YS; Wang GQ; Wen YJ; Wang L; Chen XC; Chen P; Kan B; Li J; Huang C; Lu Y; Zhou Q; Xu N; Li D; Fan LY; Yi T; Wu HB; Wei YQ
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6779-87. PubMed ID: 18006780
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
12. Construction of a DNA vaccine encoding Flk-1 extracellular domain and C3d fusion gene and investigation of its suppressing effect on tumor growth.
Liang PH; Zhang KQ; Xu GL; Li YF; Wang LF; Nie ZL; Ye J; Wu G; Ge CG; Jin FS
Cancer Immunol Immunother; 2010 Jan; 59(1):93-101. PubMed ID: 19543726
[TBL] [Abstract][Full Text] [Related]
13. Induction of protective and therapeutic antitumor immunity by a DNA vaccine with C3d as a molecular adjuvant.
Xu GL; Zhang KQ; Guo B; Zhao TT; Yang F; Jiang M; Wang QH; Shang YH; Wu YZ
Vaccine; 2010 Oct; 28(44):7221-7. PubMed ID: 20800113
[TBL] [Abstract][Full Text] [Related]
14. [Anti-tumor effects induced by the DNA vaccine coding human and mouse soluble VEGFR2].
Jin L; Zhao YW; Li ZM; Zhao CJ; Wang XF; Zhang L; Yang HS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):563-6. PubMed ID: 20848769
[TBL] [Abstract][Full Text] [Related]
15. Orally administered DNA vaccine delivery by attenuated Salmonella typhimurium targeting fetal liver kinase 1 inhibits murine Lewis lung carcinoma growth and metastasis.
Zuo SG; Chen Y; Wu ZP; Liu X; Liu C; Zhou YC; Wu CL; Jin CG; Gu YL; Li J; Chen XQ; Li Y; Wei HP; Li LH; Wang XC
Biol Pharm Bull; 2010; 33(2):174-82. PubMed ID: 20118536
[TBL] [Abstract][Full Text] [Related]
16. Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth.
Loeffler M; Le'Negrate G; Krajewska M; Reed JC
Cancer Immunol Immunother; 2009 May; 58(5):769-75. PubMed ID: 18633610
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
Fu W; Chu L; Han X; Liu X; Ren D
J Gene Med; 2008 Jun; 10(6):690-701. PubMed ID: 18338832
[TBL] [Abstract][Full Text] [Related]
18. An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
Chou CK; Hung JY; Liu JC; Chen CT; Hung MC
Cancer Gene Ther; 2006 Aug; 13(8):746-52. PubMed ID: 16410824
[TBL] [Abstract][Full Text] [Related]
19. The treatment and prevention of mouse melanoma with an oral DNA vaccine carried by attenuated Salmonella typhimurium.
Zhu X; Cai J; Huang J; Jiang X; Ren D
J Immunother; 2010 Jun; 33(5):453-60. PubMed ID: 20463603
[TBL] [Abstract][Full Text] [Related]
20. IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency.
Keyser J; Schultz J; Ladell K; Elzaouk L; Heinzerling L; Pavlovic J; Moelling K
Exp Dermatol; 2004 Jun; 13(6):380-90. PubMed ID: 15186325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
